Clinical and Biological Strokes Collection in Reunion Island

Status

Completed

Phases

Study type

Interventional

Source

ClinicalTrials.gov

Registry ID

NCT05598138

Acronym

CoBRA

Enrollment

795

Registered

2022-10-28

Start date

2021-06-22

Completion date

2023-06-21

Last updated

2023-09-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Stroke

Brief summary

Cross-sectional regional multicenter hospital study of all neurological events (stroke, AIT and mimics) for diagnostic and prognostic purposes. Cost of illness study.

Interventions

BIOLOGICALBiological Collection

A blood sample (10 ml) will be taken for each patient included in the study.

Study design

Allocation

Intervention model

SINGLE_GROUP

Primary purpose

DIAGNOSTIC

Masking

NONE

Eligibility

Sex/Gender

ALL

Age

18 Years to No maximum

Healthy volunteers

Yes

Inclusion criteria

* affiliated to a social security scheme * clinical signs suggestive of stroke : hemiparesis or hemiplegia, unilateral sensory disorder, language disorder, balance disorder, dizziness, loss of total or partial bilateral or monocular vision, sudden neurological deficit

Exclusion criteria

* current pregnancy * Recent clinical history of head trauma * patients aged \< 18 years old * patient under guardianship or curatorship * Person deprived of liberty

Design outcomes

Primary

Measure	Time frame	Description
clinico-biological score	24 hours after the stroke	area under the diagnostic score curve identifying ischemic stroke, stroke hemorrhagic or mimics.

Countries

Reunion

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026